Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy.

Pediatric blood & cancer - 1 Jul 2023

Cantor Evan, Berkovich Rachel, Navalkele Pournima, Brossier Nicole M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Ganglioglioma
Share to Mutation
Share to Proto-Oncogene Proteins B-raf

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 36916822
DOI: 10.1002/pbc.30296
PMCID: PMC10500853

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy.PMID 36916822Read ↗

The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.Semantic proximity Read ↗

Ganglioglioma with MAP2K1 Mutation and CDKN2A/B Homozygous Deletion: A Case Report.Semantic proximity Read ↗

Clinical response to dabrafenib plus trametinib in a pediatric ganglioglioma with BRAF p.T599dup mutation.Semantic proximity Read ↗

Epilepsy Outcome and Pathology Analysis for Ganglioglioma: A Series of 51 Pediatric PatientsSemantic proximity Read ↗

Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma.Semantic proximity Read ↗

Sustained Tumor Control With MAPK Inhibition in BRAF V600–Mutant Adult Glial and Glioneuronal TumorsSemantic proximity Read ↗

Ganglioglioma with novel molecular features presenting in a child with Allan-Herndon-Dudley syndrome.Semantic proximity Read ↗

A Rare Tumor in the Sellar Region: Ganglioglioma, a Case Report and a General OverviewSemantic proximity Read ↗

[Atypical ganglioglioma with BRAF V600E mutation: a case report and review of the literature].Semantic proximity Read ↗

Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade ganglioglioma.Semantic proximity Read ↗

Clinical Letter: A case report of targeted therapy with sirolimus for NPRL3 epilepsySemantic proximity Read ↗

BRAF inhibition efficacy in drug-refractory epilepsySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.